RAD51 and breast cancer: Huang and co-workers identified B02 as a specific inhibitor of human RAD51 recombinase (31) and demonstrated that B02 blocks HR repair in human embryonic kidney (HEK) and breast cancer cells and increases their sensitivity to a wide range of DNA damaging agents (32, 33).